HER-2/neu peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-014100
A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types.
| Identifier | MLC-T-ONC-014100 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | HER-2 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014100",
"term": "HER-2/neu peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine comprised of peptides derived from the extracellular domain of the tumor-associated antigen Her-2/neu with potential antineoplastic activity. HER-2/neu peptide vaccine may induce antibodies with anti-tumor activity and may also elicit a specific CD8 T-cell response against specific tumor cell types.",
"abbreviation": "HER-2",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/her-2-neu-peptide-vaccine/"
}
Record 8,420 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.